NXL Share Price Performance
US$1.86
1.24 (198.56%)
Price US$1.86
Share PriceUS$1.86
Nexalin Technology, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
NXL Community Narratives
There are no narratives available yet.
Recent NXL News & Updates
Nexalin Technology, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.51
- Gross Margin
- 67.63%
- Net Profit Margin
- -5,063.04%
- Debt/Equity Ratio
- 0%
Nexalin Technology, Inc. Competitors
Snowflake Analysis
About NXL
- Founded
- n/a
- Employees
- 6
- CEO
- WebsiteView website
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.S. Market Performance
- 7 Days: 0.8%
- 3 Months: 8.3%
- 1 Year: 17.8%
- Year to Date: 15.4%
Over the last 7 days, the market has remained flat, although notably the Utilities sector gained 3.1% in that time. Meanwhile, the market is actually up 18% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›